Literature DB >> 25578147

Targeting disease by immunomodulation.

T Kaufmann1, H U Simon1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25578147      PMCID: PMC4291496          DOI: 10.1038/cdd.2014.166

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  9 in total

Review 1.  Decisions about dendritic cells: past, present, and future.

Authors:  Ralph M Steinman
Journal:  Annu Rev Immunol       Date:  2011-11-17       Impact factor: 28.527

2.  Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation.

Authors:  James E Vince; W Wei-Lynn Wong; Ian Gentle; Kate E Lawlor; Ramanjaneyulu Allam; Lorraine O'Reilly; Kylie Mason; Olaf Gross; Stephen Ma; Greta Guarda; Holly Anderton; Rosa Castillo; Georg Häcker; John Silke; Jürg Tschopp
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

Review 3.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

Review 4.  More to life than death: molecular determinants of necroptotic and non-necroptotic RIP3 kinase signaling.

Authors:  Nufail Khan; Kate E Lawlor; James M Murphy; James E Vince
Journal:  Curr Opin Immunol       Date:  2013-11-30       Impact factor: 7.486

5.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

6.  XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation.

Authors:  Monica Yabal; Nicole Müller; Heiko Adler; Nathalie Knies; Christina J Groß; Rune Busk Damgaard; Hirokazu Kanegane; Marc Ringelhan; Thomas Kaufmann; Mathias Heikenwälder; Andreas Strasser; Olaf Groß; Jürgen Ruland; Christian Peschel; Mads Gyrd-Hansen; Philipp J Jost
Journal:  Cell Rep       Date:  2014-05-29       Impact factor: 9.423

Review 7.  Transcriptional regulation by AIRE: molecular mechanisms of central tolerance.

Authors:  Pärt Peterson; Tõnis Org; Ana Rebane
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

8.  Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo.

Authors:  D Hawiger; K Inaba; Y Dorsett; M Guo; K Mahnke; M Rivera; J V Ravetch; R M Steinman; M C Nussenzweig
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

9.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

  9 in total
  8 in total

1.  Heteroleptic Ruthenium Polypyridyl Complex Had Differential Effects on the Production of Pro-inflammatory Cytokines TNFα, IL1β, and IL6 by the Mammalian Macrophages In Vitro.

Authors:  Furkan Ayaz
Journal:  Inflammation       Date:  2019-08       Impact factor: 4.092

2.  Differential Immunomodulatory Activities of Schiff Base Complexes Depending on their Metal Conjugation.

Authors:  Furkan Ayaz; İlyas Gonul; Burcu Demirbag; Kasim Ocakoglu
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

3.  Ruthenium pyridyl thiocyanate complex increased the production of pro-inflammatory TNFα and IL1β cytokines by the LPS stimulated mammalian macrophages in vitro.

Authors:  Furkan Ayaz
Journal:  Mol Biol Rep       Date:  2018-10-04       Impact factor: 2.316

4.  Immunostimulatory Activities of Coliphages on In Vitro Activated Mammalian Macrophages.

Authors:  Gizem Yıldızlı; Gokhan Coral; Furkan Ayaz
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

Review 5.  Engineering Cell Membrane-Based Nanotherapeutics to Target Inflammation.

Authors:  Huize Yan; Dan Shao; Yeh-Hsing Lao; Mingqiang Li; Hanze Hu; Kam W Leong
Journal:  Adv Sci (Weinh)       Date:  2019-05-22       Impact factor: 16.806

Review 6.  Medicinal Profile, Phytochemistry, and Pharmacological Activities of Murraya koenigii and its Primary Bioactive Compounds.

Authors:  Rengasamy Balakrishnan; Dhanraj Vijayraja; Song-Hee Jo; Palanivel Ganesan; In Su-Kim; Dong-Kug Choi
Journal:  Antioxidants (Basel)       Date:  2020-01-24

7.  Immunomediated Pan-cancer Regulation Networks are Dominant Fingerprints After Treatment of Cell Lines with Demethylation.

Authors:  Mariama El Baroudi; Caterina Cinti; Enrico Capobianco
Journal:  Cancer Inform       Date:  2016-04-27

Review 8.  Onto better TRAILs for cancer treatment.

Authors:  D de Miguel; J Lemke; A Anel; H Walczak; L Martinez-Lostao
Journal:  Cell Death Differ       Date:  2016-03-04       Impact factor: 15.828

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.